Irene Hervás (Irene Hervas)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Low Birth Weight

Glycemic Control

Top Venues

Journal of clinical medicine

Journal of assisted reproduction and genetics

Human reproduction (Oxford, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Irene Hervás, Livia Pellegrini, Lorena Valls, Maria Gil Julia, Ana Navarro-Gomezlechon, Rocio Rivera-Egea, Laura Mossetti, Jose Maria Martinez Jabaloyas, Nicolas Garrido
Effect of time since vasectomy on live birth rate of TESE‒ICSI egg donation cycles and male-related prognostic factors. Andrology (2024)
María Gil Juliá, Mauro Cozzolino, Ana Navarro-Gomezlechon, Irene Hervás, Laura Mossetti, Rosa María Pacheco-Rendón, Rocio Rivera-Egea, Nicolas Garrido
Assessment of reproductive outcomes of fresh versus cryopreserved ejaculated sperm samples-a retrospective analysis of 44 423 oocyte donation ICSI cycles. Human reproduction (Oxford, England) (2024)
Irene Hervás, Rocio Rivera-Egea, Alberto Pacheco, María Gil Juliá, Ana Navarro-Gómez Lechón, Laura Mossetti, Nicolás Garrido
Elevated Sperm DNA Damage in IVF-ICSI Treatments Is Not Related to Pregnancy Complications and Adverse Neonatal Outcomes. Journal of clinical medicine 12 (21) (2023)
Irene Hervás, Maria Gil Julia, Rocío Rivera-Egea, Ana Navarro-Gomezlechon, Laura Mossetti, Nicolás Garrido
Switching to testicular sperm after a previous ICSI failure with ejaculated sperm significantly improves blastocyst quality without increasing aneuploidy risk. Journal of assisted reproduction and genetics 39 (10) (2022)
María Gil Juliá, Irene Hervás, Ana Navarro-Gómez Lechón, Fernando Quintana, David Amorós, Alberto Pacheco, Cristina González-Ravina, Rocío Rivera-Egea, Nicolás Garrido
Sperm Selection by Magnetic-Activated Cell Sorting before Microinjection of Autologous Oocytes Increases Cumulative Live Birth Rates with Limited Clinical Impact: A Retrospective Study in Unselected Males. Biology 10 (5) (2021)